Supplementary Figures and full Methods
Supplementary Figure 1 Supplementary Figure 1. MicroRNA-128b and miR-574 expression profiles in T-ALL samples and normal thymocyte subsets. Relative expression levels for (A) miR-128b (later annotated as miR-128-3p) and (B) miR-574 (later annotated as miR-574-3p) are indicated for the T-ALL patient samples in the different T-ALL subgroups (HOXA, TAL-LMO, TLX1, TLX3 and unknown cases), and for the normal thymocyte subsets (immature CD34 + , DP3-(CD4 + CD8 + CD3-), DP3+ (CD4 + CD8 + CD3 + ), and mature CD4 + or CD8 + stages).
PHF6 3'UTR-miRNA library screens
HEK293T cells were seeded at a density of 10,000 cells/well in 96-well plates. Twenty-four hours after seeding, cells were co-transfected with 100 ng of a reporter vector containing the wild-type PHF6 3'UTR cloned downstream of the Firefly luciferase gene (SwitchGear Genomics, Menlo Park, CA, USA) and 20 ng of the pRL-TK control vector containing the Renilla luciferase gene (Promega, Madison, WI, USA) together with a library of 470 miRNA mimics (2.5 pmol) (Ambion's Pre-miR miRNA Precursor Library -Human V3, design based on miRBase release 9.2 with exclusion of hsa-miR-122a, Life Technologies, Carlsbad, CA, USA). Lipid based transfections were performed using 0.4 µl Dharmafect Duo reagent (Dharmacon, Thermo Scientific, Waltham, MA, USA). Forty-eight hours posttransfection, luciferase reporter gene activities were assayed using the Dual-Luciferase Reporter assay system (Promega) according to the manufacturer's protocol with minor changes (LARII and Stop & Glo buffer volumes were reduced to 50 µl). Firefly reporter gene activities were normalized to Renilla values, then log-transformed and subsequently robust z-scores were calculated and median centered to the distribution of robust z-scores of 36 analogous screens for other genes on a per miRNA basis in order to remove potential systematic bias. The resulting interaction scores are thus more negative for miRNAs that interact with the 3'UTR. In order to determine the interaction score cutoff that separates interactions from non-interactions, the scores for a set of miRNA interactions validated in literature and re-evaluated in the analogous screens were used together with the scores for a set of negative control interactions from an empty 3'UTR vector miRNA library screen to perform ROC-curve analysis and determine the point of highest accuracy (interaction score cutoff= -1.94, accuracy= 91%, specificity = 99%, sensitivity = 51%). PHF6 3'UTR-miRNA library screen results were replicated in three independent experiments. For a more detailed description of the 3'UTR-miRNA library screen setup and data-analysis we refer to Van Peer et al.
(in preparation).
Single 3'UTR-miRNA reporter gene assays and rescue experiments
The Site-Directed Mutagenesis Kit (Stratagene, Agilent Technologies, Santa Clara, CA, USA) was used to generate PHF6 3'UTR reporter constructs in which miR-128-3p target sites were mutated. Sanger sequencing was used to confirm successful mutagenesis in the mutant constructs. Primer sequences used for mutagenesis:
7mer-m8 (1) FW: AAAATGTAACAGGTGGAAAATTAAAAGTTGCTTAATGACTGATTT REV: AAATCAGTCATTAAGCAACTTTTAATTTTCCACCTGTTACATTTT 7mer-m8 (2) FW: TCCTTAAAGCcAGGTGTCTAGATCATTTTTTACATTGTGTGCC REV: GGCACACAATGTAAAAAATGATCTAGACACCTGGCTTTAAGGA 7mer-m8 (3) FW: ACTACCTGTTTTTCGCCAGGTGGTGTGATTGGCT REV: AGCCAATCACACCACCTGGCGAAAAACAGGTAGT 6mer off-set FW: GACATCCATAACTACTATTCTTTTGTACATGTTTTCTAAAATC REV: GATTTTAGAAAACATGTACAAAAGAATAGTAGTTATGGATGTC HEK-293T cells were co-transfected with the wild-type/mutant 3'UTR vector of PHF6 (SwitchGear Genomics) and a pRL-TK control vector (Promega) together with either the miRNA mimic of interest (Ambion, PM11746, 4427975) or a scrambled, non-targeting control (NTC) miRNA mimic (Ambion, AM17111). Transfections and luciferase measurements were performed as described above.
Transfection/electroporation of miRNA mimics or LNAs in cell lines
HEK-293T cells were seeded in 6-well culture plates at a density of 200,000 cells per well, 24 hours prior to transfection. Cells were transfected using Dharmafect2 (Thermo Scientific) at a final concentration of 0.4 % and a final concentration of 100 nM miRNA mimics (Ambion). T-ALL cell lines ALL-SIL and Jurkat were transfected with miRNA mimics by electroporation. Briefly, for each electroporation, 16 x10 6 cells were suspended in 500 µl RPMI medium. MicroRNA mimics were then added to the cell suspension (final concentration 600 nM). Next, cells were transferred to an electroporation tube and electroporated (0.250 kV and 1 mF) with the Gene Pulser II (Bio-Rad). Cells from one electroporation were then divided over four 12-well plates to a final cell suspension of 3.2 x10 6 cells in 2 ml RPMI-1640 + 15% FCS. Cells were incubated at 37°C and collected for protein and RNA isolation after 24, 48, 72 and 96 hours (see further). For miR-128-3p knock down studies, Jurkat cells were electroporated with miR-128 specific LNAs (miRCURY LNA TM microRNA Power inhibitor, #426742-00, Exiqon, Vedbaeck, Denmark) or nontargeting control LNAs (Power control A, #500150). LNAs (final concentration 400 nM) were electroporated at 0.300 kV and 1 mF with the Gene Pulser II.
RNA isolation, cDNA synthesis and RT-qPCR
Total RNA was isolated with the miRNeasy Mini Kit (Qiagen, Hilden, Germany) and DNase-treated (RNase-Free DNase Set, Qiagen) according to the manufacturer's protocol. RNA concentration and purity was measured using the Nanodrop instrument (Thermo Scientific, Waltham, MA, USA). cDNA synthesis was performed on 500 ng total RNA with 4 μl of iScript reaction mix and 1 μl of iScript reverse transcriptase (iScript, Bio-Rad, Hercules, CA, USA) in a final volume of 20 μl. Subsequently, this mix was incubated for 5′ at 25°C, 30′ at 42°C and 5′ at 85°C using the iCycler (Bio-Rad).
RT-qPCR gene expression quantifications were performed and reported according to the MIQE guidelines where appropriate (5) . All reactions were performed in 384-well plates using 5 ng cDNA, 2.5 μl of SsoAdvanced (Bio-Rad) mastermix and 250 nM primers in a total volume of 5 μl. The readout was performed by use of the LightCycler 480 instrument (Roche, Basel , Switzerland). All qPCR reactions were performed in duplicate and Cq values were averaged.
Expression levels were normalized against at least three out of four stably expressed reference genes per experiment (for HEK293T: HMBS, SDC4, SDHA, TBP; for ALL-SIL: UBC, YWHAZ, HMBS, HPRT1; for Jurkat: B2M, SDC4, SDHA, TBP; for mouse samples: tbp, ubc and ppia) and analyzed using qbase+ software (http://www.biogazelle.com). All qPCR assays were extensively validated in silico using the primerXL (http://www.primerxl.org/) pipeline and empirically validated, checking both primer efficiency and specificity.
Primer sequences used for RT-qPCR assays in these studies, listed per gene (* mouse genes; rest are human): 
Gene

PHF6
AAAAGGGCCTACAAGACAG ACAATGGCACAAAGAACAC
IKZF1
ACCCGAGGATCAGTCTTG TCCATGGTCCTCAGGTTAT
NF1
AGCACAACAAGGAATGTCTAA GCTTCTCCAAATATTCTCATATTGTT
PTEN
CCGAAAGGTTTTGCTACCATTCT AAAATTATTTCCTTTCTGAGCATTCC
BAX
GATGCGTCCACCAAGAAGCT CGGCCCCAGTTGAAGTTG
FBXW7
TGGGATATCAAAACAGGACAGTGT TAAACAGGTCACAGCACTCTGATG
E2F5
CCTGTTCCCCCACCTGATG TTTCTGTGGAGTCACTGGAGTCA
SUZ12
AACAGCCATATGGTGAAGTC CTGGAAGCTCTTCATTGACA
HMBS
GGCAATGCGGCTGCAA GGGTACCCACGCGAATCAC
SDHA
TGGGAACAAGAGGGCATCTG CCACCACTGCATCAAATTCATG
TBP
CACGAACCACGGCACTGATT TTTTCTTGCTGCCAGTCTGGAC
UBC
ATTTGGGTCGCGGTTCTTG TGCCTTGACATTCTCGATGGT
YWHAZ
ACTTTTGGTACATTGTGGCTTCAA CCGCCAGGACAAACCAGTAT
HPRT1
TGACACTGGCAAAACAATGCA GGTCCTTTTCACCAGCAAGCT
B2M
TGCTGTCTCCATGTTTGATGTATCT TCTCTGCTCCCCACCTCTAAGT
Protein isolation and Western blot
Cells were washed with ice-cold PBS and snap-frozen in liquid nitrogen. Cells were lysed in RIPA lysis buffer (32 mM Na + -DOC, 150 mM NaCl, 50 mM TrisHCl (pH 7.5), 0.1 % SDS en 1 % NP-40) supplemented with protease inhibitors (Complete Protease Inhibitor Cocktail Tablets, Roche), incubated for minimum 30 minutes at 4 °C under rotating conditions, and finally centrifuged (8000 g, 10 minutes, 4 °C) to obtain cleared lysate fractions. Per fraction, 20 µl lysate was combined with 5µl of a denaturation buffer mix (5x laemmli buffer (25 ml 10 % SDS-solution, 20 ml 100 % glycerol, 7.75 ml 1 M TrisHCl pH 6.8 en 1.25 ml 1 % Bromo Phenol Blue solution), 1:7 40x β-mercaptoethanol), and incubated at 95°C for 10 min in a shaker. Denatured fractions were subsequently loaded on precast gels (Bio-Rad; 10% SDS) and subjected to SDS-PAGE (100 V and 0.25 A, 1-2 hours). Proteins were then transferred onto a nitrocellulose membrane (nitrocellulose/Filter Paper Sandwiches 0.2µm, Bio-Rad) (100 V, 0.25 A, 1-2 hours). Membranes were blocked with a solution of 5% non-fat milk in 1x TBST for 1 hour and then probed with primary antibodies dissolved in 5% milk/TBST by overnight incubation at 4°C. Primary antibodies used in this study are anti-PHF6 (rabbit, Cell Signaling (Danvers, MA, USA), 7076S, dilution 1/2000; rabbit, Sigma, HPA001023, dilution 1/2000), anti-α-tubuline (mouse, Sigma (St. Louis, MI, USA, T5168, dilution 1/5000) and anti-β-actin (mouse, Sigma, A5316, dilution 1/5000). Membranes were then 3 times washed for 5 minutes with 1x TBST and probed with HRP-linked secondary antibodies dissolved in 5% milk/TBST for 1 hour. Secondary antibodies used in this study are HRP-linked anti-mouse and anti-rabbit (Cell Signaling, dilution 1/5000). Finally, membranes were washed 3 times for 5 min with 1xTBST, incubated with luminal/enhancer buffer (SuperSignal West Dura Extended Duration Substrate, Thermo Scientific) and developed by chemiluminescent detection using the UCP chemiDoc-it ® 500 Imaging System (UVP). To remove antibodies from the blots, membranes were incubated with stripping buffer (Restore PLUS Western Blot Stripping Buffer, Thermo Scientific) for 15 minutes, washed for 5 times (5 minutes per wash) with 1x TBST, and blocked with 5% milk/TBST before probing with another primary antibody.
Rank Products analysis
MicroRNAs differentially expressed (pfp-value <0.05) between T-ALL patient samples and normal thymocyte subsets were identified using Rank Products analysis (RankProd package) in the R statistical programming environment (version 3.0.1).
MicroRNA nomenclature and annotation
During the course of this study, official nomenclature an sequence annotation as put forward by the miRBase database (http://www.mirbase.org/) changed for the miRNAs investigated here. At the start of our study, miR-574 (mature sequence CACGCUCAUGCACACACCCAC) and both miR-128a (mature sequence UCACAGUGAACCGGUCUCUUUU) and miR-128b (mature sequence UCACAGUGAACCGGUCUCUUUC) were annotated in miRBase (release 9.2), and all three were included in the miRNA library for the PHF6 3'UTR screens and the library for miRNA profiling of the T-ALL patient samples and normal thymocytes. In the miRNA library screens for PHF6, miR-574 and miR-128b were found to be hits (see Supplementary Table 1) . However, at the start of our validation studies, miRBase merged the records of miR-128a and miR-128b into a single record, miR-128 (accession number MIMAT0000424), with a mature sequence (UCACAGUGAACCGGUCUCUUU) that is one nucleotide shorter than the sequences of the previously annotated miR-128a and miR-128b. Also miR-574 was reannotated to miR-574-3p (mature sequence CACGCUCAUGCACACACCCAC), which is one nucleotide longer at the 3' end. Therefore, we used these newly annotated miR-128 and miR-574-3p sequences in our follow-up experiments, including the validation luciferase (and rescue) assays in HEK293T (Figure 3) , and the miRNA overexpression experiments in HEK293T (Figure 4) and T-ALL cell lines ( Figure 5 and Supplementary Figures 2-4) . We speculated that, since the sequence changes occurred 3' of the miRNA's sequences, it is likely that the newly annotated miR-128 and miR-574-3p sequences are functionally redundant, as the seed regions remain unchanged. We could indeed confirm in follow-up experiments that PHF6 is equally regulated by miR-128 and miR-574-3p in HEK293T. In the most recent release of miRBase (release 20), the human mature miR-128 sequence (UCACAGUGAACCGGUCUCUUU) was renamed miR-128-3p. In this manuscript, we use the most up-to-date names at time of publication for the miRNAs under investigation, miR-128-3p and miR-574-3p. For the miRNA overexpression studies in mouse, the human pre-miR-128-2 sequence was used, which gives rise to mature miR-128-3p.
T-ALL mouse model
For the mouse work, the institutional and national guide for the care and use of laboratory animals was followed. Fetal liver cells from mice were isolated at embryonic day 13-14 and retrovirally transduced with ICN1 (active NOTCH1, labeled with mCherry) expression vectors in combination with miR-128-3p expression vectors or empty vector controls (labeled with GFP). The transduced fetal liver cells were subsequently injected in the tail vein of lethally irradiated mouse recipients. The onset of leukemia in these mice was then monitored by analysis of lymphoblast counts in blood smears and physical appearance. At diagnosis, several tissues (spleen, lung, liver, kidney) were fixed for histological evaluation. Additional FACS analysis was performed to confirm that tumor cells are GFP-positive in the miR-128-3p overexpressing mice. Time-to-leukemia onset data were analyzed using the Kaplan-Meier method and the log-rank (Mantel-Cox) test for statistical significance.
Histology and immunohistochemistry (IHC) of mouse tumor samples
Dissected tissue samples were formalin fixed overnight at 4 °C, washed in PBS and paraffin-embedded according to standard procedures. Paraffin-embedded tissues were sectioned at 5 m and stained with hematoxylin and eosin (H&E). Additional IHC staining was performed for Ki67. First, antigen retrieval was done in citrate buffer, pH 6 (Dako, Glostrup, Denmark) using an electric pressure cooker (PickCell Laboratories, The Netherlands). Colorimetric staining was performed using a rabbit polyclonal anti-Ki67 primary antibody (Cell Signaling, dilution 1/1000) and a biotinylated goat anti-rabbit secondary antibody (Dako, dilution 1/500) with Vectastain Elite ABC reagent (Vector Labs, Burlingame, CA, USA). Visualisation was done using DAB kit (Dako) and counterstained with hematoxylin. Stainings were analyzed with a BX51 Discussion microscope (Olympus, Shinjuku, Tokyo, Japan). Representative pictures were made with a cooled interline CCD camera. -9,018 hsa-mir-217 -9,040 hsa-mir-455 -9,073 hsa-mir-627 -9,078 hsa-mir-487a -9,092 hsa-mir-372 -9,141 hsa-mir-551b -9,172 hsa-mir-432 -9,200 hsa-mir-373 -9,202 hsa-miR-641 -9,208 hsa-mir-202 -9,219
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